title: Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.
abstract: A comparative study of the loading and retention properties of three structurally very closely related vinca alkaloids (vincristine, vinorelbine and vinblastine) in liposomal formulations has been performed. All three vinca alkaloids showed high levels of encapsulation when accumulated into egg sphingomyelin/cholesterol vesicles in response to a transmembrane pH gradient generated by the use of the ionophore A23187 and encapsulated MgSO4. However, despite the close similarities of their structures the different vinca drugs exhibited very different release behavior, with vinblastine and vinorelbine being released faster than vincristine both in vitro and in vivo. The differences in loading and retention can be related to the lipophilicity of the drugs tested, where the more hydrophobic drugs are released more rapidly. It was also found that increasing the drug-to-lipid ratio significantly enhanced the retention of vinca alkaloids when the ionophore-based method was used for drug loading. In contrast, drug retention was not dependent on the initial drug-to-lipid ratio for vinca drugs loaded into liposomes containing an acidic citrate buffer. The differences in retention can be explained on the basis of differences in the physical state of the drug inside the liposomes. The drug-to-lipid ratio dependence of retention observed for liposomes loaded with the ionophore technique may provide a way to improve the retention characteristics of liposomal formulations of vinca drugs.
authors.affiliation: Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of British Columbia, 2146 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada. igorvj@interchange.ubc.ca
authors.forename: Igor V
authors.initials: IV
authors.lastname: Zhigaltsev
authors.forename: Norbert
authors.initials: N
authors.lastname: Maurer
authors.forename: Quet-Fah
authors.initials: QF
authors.lastname: Akhong
authors.forename: Robert
authors.initials: R
authors.lastname: Leone
authors.forename: Esther
authors.initials: E
authors.lastname: Leng
authors.forename: Jinfang
authors.initials: J
authors.lastname: Wang
authors.forename: Sean C
authors.initials: SC
authors.lastname: Semple
authors.forename: Pieter R
authors.initials: PR
authors.lastname: Cullis
mesh_terms: D000818:Animals; D000001:Calcimycin / Q000737:chemistry; D005260:Female; D007275:Injections, Intravenous; D007476:Ionophores / Q000737:chemistry; D008081:Liposomes; D008278:Magnesium Sulfate / Q000737:chemistry; D051379:Mice; D008813:Mice, Inbred ICR; D012995:Solubility; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000493:pharmacokinetics*; D014750:Vincristine / Q000008:administration & dosage / Q000737:chemistry* / Q000493:pharmacokinetics*; D000077235:Vinorelbine
chemical_list: D007476:Ionophores; D008081:Liposomes; D000001:Calcimycin; D014750:Vincristine; D014747:Vinblastine; D008278:Magnesium Sulfate; D000077235:Vinorelbine